MRRS adds "Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s, ‘Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) – Pipeline Review, H2 2016’, provides in depth analysis on Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) targeted pipeline therapeutics.

The report provides comprehensive information on the Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) targeted therapeutics development and features dormant and discontinued projects.

Table Of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Overview 8
Therapeutics Development 9
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Products under Development by Stage of Development 9
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Products under Development by Therapy Area 10
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Products under Development by Indication 11
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Products Glance 13
Late Stage Products 13
Early Stage Products 14
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Products under Development by Companies 15
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Products under Development by Universities/Institutes 18
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Therapeutics Assessment 20
Assessment by Monotherapy/Combination Products 20
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Companies Involved in Therapeutics Development 27
Bionomics Limited 27
Catalyst Biosciences, Inc. 28
CoMentis, Inc. 29
Johnson & Johnson 30
Merck & Co., Inc. 31
NeuroDerm Ltd. 32
Saniona AB 33
SK Biopharmaceuticals Co., Ltd. 34
Sunovion Pharmaceuticals Inc. 35
Vanda Pharmaceuticals Inc. 36
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drug Profiles 37
(nicotine + opipramol hydrochloride) - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
AN-761 - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
AQW-051 - Drug Profile 39
Product Description 39
...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/neuronal-acetylcholine-receptor-subunit-alpha-7-chrna7-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.